We only have this paper's title and publication details.
Read it at the sourcePGRN might be considered as a marker for diabetic microangiopathy and its severity.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: